TDO2 and hepatocellular carcinoma: A hepatic‐Tdo2‐specific KO mouse is being constructed and the long‐term effects of TDO2 inhibition on liver function and overall metabolism (such as hepatic fibrosis, cirrhosis and even hepatocellular carcinoma) would be systematically studied in the near future.